1 CT.gov Train-the-Trainer Survey

OMB Control Number: 0925-0648
Expiration Date: 05/31/2021
Public reporting burden for this collection of information is estimated to average 5 minutes per response,
including the time for reviewing instructions, searching existing data sources, gathering and maintaining
the data needed, and completing and reviewing the collection of information. An agency may not conduct
or sponsor, and a person is not required to respond to, a collection of information unless it displays a
current valid OMB control number. Send comments regarding this burden estimate or any other aspect of
this collection of information, including suggestions for reducing this burden to NIH Project Clearance
Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA (0925-0648). Do not
return the completed form to this address.

ClinicalTrials.gov Train-the-Trainer Feedback Survey
Please rate the usefulness of the following educational formats for the workshop:
Very Useful
(1)
Lecture (1)
Interactive
Discussion
(2)
Hands-on
Time (3)

Somewhat
Useful (2)

Neither
Useful nor
Useless (3)

Not Useful
(4)

Useless (5)

I don't
know (6)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

Comments/clarifications about the format of the workshop:
________________________________________________________________
How appropriate was the length of the workshop?

o Too long (1)
o Just right (2)
o Not long enough (3)

Comments/clarifications about the length of the workshop:
________________________________________________________________

o

How much novel information and/or skills did you learn about each section that you did not
know before?
A lot of new
info/skills (1)

Some new
info/skills (2)

No new
info/skills, I
already knew
this (3)

I don't know (4)

Overview of the
Clinical Trial
Disclosure
Landscape (1)

o

o

o

o

NIH Office of
Extramural
Research (OER)
Perspective (2)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

Managing
Registration and
Results
Reporting at and
Academic
Institution (3)
Participant Flow
Module (4)
Baseline
Characteristics
Module (5)
Protocol
Registration and
Results System
Overview (6)
PRS Guided
Tutorials
Overview (7)
Outcome
Measures
Module (8)
Adverse Events
Module (9)

o

o

o

o

o

o

Comments/clarifications about what you learned:
________________________________________________________________

o

o

After participating in this workshop, how confident do you feel in your ability to help your
colleagues with questions about the following topics:
Very
confident
(1)
Overview of
the Clinical
Trial
Disclosure
Landscape (1)
NIH Office of
Extramural
Research
(OER)
Perspective
(2)
Managing
Registration
and Results
Reporting at
and Academic
Institution (3)
Participant
Flow Module
(4)
Baseline
Characteristics
Module (5)
Protocol
Registration
and Results
System
Overview (6)
PRS Guided
Tutorials
Overview (7)
Outcome
Measures
Module (8)
Adverse
Events (9)

Somewhat
confident
(2)

More
confident
than
before (3)

Not
confident
(4)

I could not
answer
anyone
else's
questions
(5)

I don't
know (6)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

Comments/clarifications about your confidence in helping colleagues with their questions:
________________________________________________________________
What did you like most or find most helpful about the Train-the-Trainer Workshop?
________________________________________________________________
What did you like least or find least helpful about the Train-the-Trainer Workshop? How could
the Workshop improve?
________________________________________________________________
Do you have any questions or concerns that were not addressed as a part of the Train-theTrainer Workshop? How could they be better addressed?
________________________________________________________________
What additional resources and information would be useful to you, your institution, or your
colleagues for reporting to ClinicalTrials.gov
________________________________________________________________